期刊文献+

GM-CSF抗体在免疫正常格特隐球菌感染中的作用研究 被引量:1

Role of anti-granulocyte-macrophage colony-stimulating factor autoantibodies in cryptococcal meningoencephalitis by cryptococcus gattii in immunocompetent patients
下载PDF
导出
摘要 目的探讨抗粒细胞-巨噬细胞集落刺激因子(GM-CSF)抗体在免疫正常格特隐球菌感染患者中的作用。方法分为两组,病例组为7例无免疫异常状态的隐球菌性脑膜脑炎患者,健康对照组为7名健康人,分别检测抗GM-CSF抗体。并对隐球菌性脑膜脑炎患者的脑脊液进行菌株分离培养及鉴定。结果 7例患者中6例为新生隐球菌感染,1例为格特隐球菌感染。抗GM-CSF抗体只在格特隐球菌感染的患者血浆中发现,而在新生隐球菌感染的患者中未发现。健康对照组中1例检测到抗GM-CSF抗体。结论在"免疫正常"的隐球菌脑膜脑炎患者中,抗GM-CSF抗体可能为格特隐球菌感染的危险因素,而与新生隐球菌感染无关。 Objective To discuss the role of anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies in central nervous system infection by cryptococcus ( C, ) gattii in immunocompetent patients. Methods Group A included seven immunocompetent patients with cryptococcal menlngoencephalitis, Group B included seven healthy volunteers as controls. Results In group A, six patients were infected with C, neoformans, and the other one with C. gattii. Anti-GM-CSF autoantibodies were positive in the one infected by C. gattii and negative in those infected by C. neoformans, In Group B, the antibodies were found only in one volunteer. Conclusion It is suggested that anti-GM-CSF autoantibodies may predispose the immunocompetent individuals to meningoencephalitis caused by C. gattii but not necessarily to that caused by C. neoformans.
作者 金怡 陈江汉
出处 《临床军医杂志》 CAS 2014年第6期611-613,648,共4页 Clinical Journal of Medical Officers
关键词 抗粒细胞-巨噬细胞集落刺激因子抗体 格特隐球菌 免疫正常 anti-granulocyte-macrophage colony-stimulating factor autoantibody cryptococcus gattii immunocompetent
  • 相关文献

参考文献1

二级参考文献86

  • 1Fensterle J, Grode L, Hess J, Kaufmann SH. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun. J Immunol 1999; 163:4510-8.
  • 2Kim J J, Ayyavoo V, Bagarazzi ML, et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997;158:816-26.
  • 3Mach N, Dranoff G. Cytokine-secreting tumor cell vaccines.Curr Opin Immunol 2000; 12:571-5.
  • 4DranoffG, ,laffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 1993: 90:3539-43.
  • 5Mach N, Gillessen S, Wilson SB, et al. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.Cancer Res 2000; 60:3239-46.
  • 6Nieuwenhuis EE, Gillessen S, Scheper RJ, et al. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp Dermatol 2005; 14:250-8.
  • 7Gillessen S, Naumov YN, Nieuwenhuis EE, et al, CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion, Proc Natl Acad Sci U S A 2003;100:8874-9.
  • 8Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
  • 9Tao MH, Levy R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 1993; 362:755-8.
  • 10Hamilton JA, Stanley ER, Burgess AW Shadduck RK. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 1980: 103:435-45.

共引文献21

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部